BOE
BGY
CII
BDJ
BGR

Kyle McClements

CIK: 0001320768

Kyle McClements's purchase track record

How the stock did after each of Kyle McClements's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.

Purchases measured
4
of 4 since December 14, 2021
Stock higher 6 months later
75%
3 months: 75%
Median 6-month return
+10.3%
3 months: +4.4%
Beat the S&P 500
50%
median -3.3% vs. index
PurchaseStockAmount3 months6 months
1/22/2024BSTZ$17K+3.7%+22.1%
12/27/2023BMEZ$15K+12.1%+6.0%
1/11/2023BSTZ$7K+5.2%+14.6%
12/14/2021BTX$15K-21.7%-42.0%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

this person other insiders at BGY

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 1, 2026

BlackRock Closed‑End Funds Announce Distribution Sources. BlackRock has announced the estimated sources of distributions for several of its closed‑end funds. CII, a BlackRock closed‑end fund, is included in this update, giving investors clearer insight into where the fund’s income will come from. The announcement does not change the fund’s current dividend yield of 6.83% or its price range, but it may help investors assess future cash flow.

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 1, 2026

BlackRock Closed-End Funds Release Estimated Distribution Sources. BlackRock has announced the estimated sources of distributions for several of its closed‑end funds, including BDJ. The disclosure gives investors a clearer view of where the fund’s future payouts will come from. This may influence how investors assess the fund’s income potential. The update is a routine disclosure that helps keep the market informed about the fund’s distribution strategy.

this person other insiders at BDJ

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 30, 2026

Bond Market Turmoil Could Impact BGR. Bond market volatility may create challenges for BGR, a tech‑heavy fund. The article notes that rising bond yields could pressure the fund’s performance. BGR’s current RSI is neutral and it trades near the middle of its 52‑week range. Stakeholders should watch how bond market conditions evolve.

this person other insiders at BGR

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 27, 2026

BMEZ Q2 2026 Commentary Released on SeekingAlpha. A Q2 2026 commentary for BlackRock Health Sciences Term Trust was published on SeekingAlpha. The report reviews the trust’s recent performance and outlook. This update adds fresh information for investors as the share trades near its 52‑week low.

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 1, 2026

BlackRock CEFs Announce Estimated Sources of Distributions. BlackRock has announced the estimated sources of distributions for certain closed-end funds, including the Science and Technology Term Trust. This disclosure provides transparency on how payouts are generated, which is a key consideration for income-focused holders. The fund's low trailing P/E of 1.9 suggests a valuation profile that may be sensitive to such distribution details.

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 25, 2026

BME Cited In Healthcare Fund Yield Discussion. Blackrock Health Sciences Trust (BME) was mentioned in a SeekingAlpha article discussing healthcare funds with yields over 10%. The piece highlights the fund's income potential, which may draw attention from investors seeking steady returns in the sector. This mention places BME in the context of high-yield options, though the article does not provide specific new financial data for the trust.

this person other insiders at BME

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 16, 2026

Insiders Buy Into Bluerock Private Real Estate Fund. Recent reports indicate that insiders have purchased shares in the Bluerock Private Real Estate Fund, a move often interpreted as a sign of internal confidence in the fund's outlook. This development provides context for BTX, which is currently trading near its support level with a low RSI, suggesting the stock may be in a corrective phase despite the positive insider activity.

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

BCX noted as potential income play after 3.6% Social Security increase. The government announced a 3.6% increase in Social Security benefits. This boost to retirement income may lead income‑focused investors to look at dividend‑paying stocks such as BCX, which offers a 6.91% yield. The company's low trailing P/E of 4.7 also suggests value appeal. The news does not directly involve BCX but could influence demand for its shares.

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

BST seen as portfolio option after 3.6% Social Security rise. The government announced a 3.6% increase in Social Security benefits. This change may affect investors who focus on income‑generating assets, and some may look at trusts like BST as part of a diversified portfolio. BST currently trades with a low trailing P/E of 2.7 and is near the lower end of its 52‑week range, which adds valuation context to the discussion.

Transaction History

BOE▼ Sell$32K
BGY▼ Sell$7K
CII▲ Buy—
CII▼ Sell$36K
BDJ▲ Buy—
BDJ▼ Sell$32K
BOE▲ Buy—
BGY▲ Buy—
BGR▲ Buy—
BGR▼ Sell$34K
BOE▲ Buy—
BGY▲ Buy—
BMEZ▲ Buy—
BMEZ▼ Sell$10K
BGY▼ Sell$18K
BDJ▲ Buy—
BDJ▼ Sell$29K
BOE▼ Sell$30K
CII▲ Buy—
CII▼ Sell$31K
BSTZ▲ Buy—
BME▲ Buy—
BME▼ Sell$26K
BSTZ▼ Sell$21K
BGR▲ Buy—
BGR▼ Sell$31K
BTX▲ Buy—
BTX▼ Sell$10K
BCX▲ Buy—
BCX▼ Sell$17K
BST▲ Buy—
BST▼ Sell$28K
BUI▲ Buy—
BUI▼ Sell$19K
BOE▲ Buy—
BOE▼ Sell$26K
BGY▲ Buy—
BGY▼ Sell$26K
BDJ▲ Buy—
BDJ▼ Sell$27K
CII▲ Buy—
CII▼ Sell$31K
BSTZ▲ Buy—
BME▲ Buy—
BME▼ Sell$26K
BSTZ▼ Sell$13K
BGR▲ Buy—
BGR▼ Sell$36K
BCX▼ Sell$27K
BST▲ Buy—
BST▼ Sell$24K
BCX▲ Buy—
BUI▲ Buy—
BUI▼ Sell$25K
BSTZ▲ Buy$17K
BMEZ▲ Buy$7K
BMEZ▲ Buy$8K
BOE▲ Buy—
BOE▼ Sell$27K
BGY▼ Sell$30K
BGY▲ Buy—
BDJ▲ Buy—
BDJ▼ Sell$31K
BME▲ Buy—
BME▼ Sell$27K
CII▲ Buy—
CII▼ Sell$22K
BGR▲ Buy—
BGR▼ Sell$43K
BSTZ▲ Buy—
BSTZ▼ Sell$12K
BCX▲ Buy—
BCX▼ Sell$35K
BUI▲ Buy—
BUI▼ Sell$25K
BST▲ Buy—
BST▼ Sell$21K
BSTZ▲ Buy$7K
BGY▲ Buy—
BOE▲ Buy—
BOE▼ Sell$31K
BDJ▲ Buy—
BDJ▼ Sell$33K
BGY▼ Sell$33K
BSTZ▲ Buy—
BME▲ Buy—
BME▼ Sell$29K
CII▲ Buy—
CII▼ Sell$27K
BSTZ▼ Sell$9K
BGR▲ Buy—
BGR▼ Sell$34K
BCX▲ Buy—
BCX▼ Sell$34K
BST▲ Buy—
BST▼ Sell$34K
BUI▲ Buy—
BUI▼ Sell$30K
BTX▲ Buy$15K
BGR▲ Buy—
BGR▼ Sell$19K
BOE▲ Buy—
BOE▼ Sell$29K
BGY▲ Buy—
BGY▼ Sell$33K
BGR▼ Sell$31K
BGR▲ Buy—
BGY▲ Buy—
BGY▼ Sell$37K
BOE▲ Buy—
BOE▼ Sell$37K
BGR▼ Sell$21K
BGY▲ Buy—
BGY▼ Sell$23K
BOE▲ Buy—
BOE▼ Sell$23K
BGR▲ Buy—
BOE▲ Buy—
BOE▼ Sell$15K

We use analytics to understand how market-wall is used. No personal data is sold.